Highnoon Laboratories Limited (KASE: HINOON)
Health Care · Pharmaceuticals · PK
PKRs929.10
+0.01% today · -18.0% 1Y
Highnoon Laboratories Limited (KASE: HINOON) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $177.77M.
Over the last twelve months the share price has lost 18.0%, trading between 755.56 and 1.22K.
Tweenvest scores Highnoon Laboratories Limited across four factors: quality 86/100, value 71/100, growth 79/100, dividend 100/100. Its strongest factor is dividend.
HINOON price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $177.77M
- Revenue (TTM)
- $102.54M
- P/E
- 11.79
- EPS
- 78.82
- Dividend yield
- 5.38%
- Beta (5Y)
- 0.10
- 52-week high
- PKRs1,224.00
- 52-week low
- PKRs755.56
- Avg volume (3M)
- —
- Shares outstanding
- 52.98M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Samjin Pharmaceuticals Co., Ltd.KOSE: A005500 | $183.27M | ₩20,100.00 | +5.35% |
| Fidson Healthcare PlcNGSE: FIDSON | $180.69M | ₦83.00 | +1.22% |
| Oramed Pharmaceuticals Inc.NasdaqCM: ORMP | $180.12M | $4.25 | -1.85% |
| Journey Medical CorporationNasdaqCM: DERM | $178.10M | $5.92 | -6.26% |
| IT-Chem CO.,LtdKOSDAQ: A309710 | $173.78M | ₩— | — |
| Jilin Province Huinan Changlong Bio-pharmacy Company LimitedSEHK: 8049 | $172.77M | HK$2.42 | +4.09% |
| Kahira Pharmaceuticals & Chemical Industries CompanyCASE: CPCI | $171.93M | EGP602.90 | +1.21% |
| JBM (Healthcare) LimitedSEHK: 2161 | $169.76M | HK$1.63 | +1.88% |
Figures last refreshed Oct 11, 2026.